| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| X4 Pharmaceuticals, Inc | Director | Common Stock | 96.7K | $85.2K | $0.88 | Jun 10, 2024 | Direct |
| Aeglea BioTherapeutics, Inc. | Director | Stock Option (right to buy) | 1.95M | Jun 22, 2023 | Direct | ||
| Dianthus Therapeutics, Inc. /DE/ | Director | Stock Option (Right to Buy) | 11K | May 23, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| XFOR | X4 Pharmaceuticals, Inc | Jun 10, 2024 | 1 | $0 | 4 | Jun 11, 2024 | Director |
| DNTH | Dianthus Therapeutics, Inc. /DE/ | May 23, 2024 | 1 | $0 | 4 | May 28, 2024 | Director |
| MGTA | Dianthus Therapeutics, Inc. /DE/ | Sep 11, 2023 | 1 | $0 | 4 | Sep 13, 2023 | Director |
| AGLE | Aeglea BioTherapeutics, Inc. | Jun 22, 2023 | 1 | $0 | 4 | Jun 30, 2023 | Director |
| XFOR | X4 Pharmaceuticals, Inc | Jun 13, 2023 | 1 | $0 | 4 | Jun 14, 2023 | Director |
| MGTA | Magenta Therapeutics, Inc. | Jun 28, 2022 | 1 | $0 | 4 | Jun 30, 2022 | Director |
| AGLE | Aeglea BioTherapeutics, Inc. | Jun 7, 2022 | 1 | $0 | 4 | Jun 10, 2022 | Director |
| XFOR | X4 Pharmaceuticals, Inc | Jun 6, 2022 | 1 | $0 | 4 | Jun 27, 2022 | Director |
| AGLE | Aeglea BioTherapeutics, Inc. | Jun 8, 2021 | 1 | $0 | 4 | Jun 9, 2021 | Director |
| XFOR | X4 Pharmaceuticals, Inc | Jun 2, 2021 | 1 | $57K | 4 | Jun 2, 2021 | Director |
| MGTA | Magenta Therapeutics, Inc. | Jun 1, 2021 | 1 | $0 | 4 | Jun 3, 2021 | Director |